FibroGen Inc
(NAS:FGEN)
$
0.373
-0.0107 (-2.79%)
Market Cap: 37.45 Mil
Enterprise Value: 44.20 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 42/100 FibroGen Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 08, 2022 / 06:05PM GMT
Release Date Price:
$15.05
(-2.46%)
Operator
(Operator Instructions) At this time, it is my pleasure to turn the program over to our host, Jason Gerberry.
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Thank you, and good day, everybody. Thanks for joining us at the Bank of America Biotech Virtual Conference here. My name is Jason Gerberry. I'm one of the Biotech Analyst and I'm pleased to be introducing FibroGen, our next company presenter and CEO, Enrique Conterno. Enrique, first off, just thanks for joining us.
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
Well, thank you very much for the invitation, Jason.
Questions & Answers
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Great, great. So I think it probably makes sense if we talk a little bit about pipeline first and then we can work our way backwards to some of the commercial elements of the FibroGen company story if that works for you. Maybe -- we'll start with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot